Angle (AGL)


Latest News

Holding(s) in Company

RNS Number: 0043M Angle PLC 07 October 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Angle Plc 2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights Yes An acquisition or disposal o...

Result of AGM

RNS Number: 6867L Angle PLC 04 October 2016 For Immediate Release 4 October 2016 ANGLE plc ("ANGLE" or "the Company") Result of 2016 Annual General Meeting ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that Resolutions 1 to 8 and Resolution 10 put to its shareholders at today's 2016 Annual General Meeting were...

ANGLE notes research results in Clinical Chemistry

ANGLE has announced that University Medical Centre Hamburg-Eppendorf has published new research detailing the us...

Research published in Clinical Chemistry

RNS Number: 2625L Angle PLC 30 September 2016 For immediate release 30 September 2016 ANGLE plc ("ANGLE" or "the Company") RESEARCH DEMONSTRATES POTENTIAL USE OF PARSORTIX IN ASSESSING CHEMOTHERAPY RESISTANCE Fourth peer-reviewed publication - highlights key Parsortix advantages University Medical Centre Hambu...

All News

07-10-16Holding(s) in CompanyRNS
04-10-16Result of AGMRNS
30-09-16ANGLE notes research results in Clinical ChemistryStockMarketWire
30-09-16Research published in Clinical ChemistryRNS
19-09-16Issue of EquityRNS
09-09-16Annual Report and Accounts and Notice of AGMRNS
04-08-16MD Anderson Cancer Center poster presentationRNS
02-08-16Edison issues ADR update on AngleRNS
28-07-16ANGLE revenue upStockMarketWire
28-07-16Use of Parsortix in GANNET53 drug trialRNS
28-07-16Preliminary ResultsRNS
27-07-16ANGLE initiates ovarian cancer study in the USStockMarketWire
27-07-16Initiation of 200 patient US ovarian cancer studyRNS
19-07-16ANGLE initiates European ovarian cancer study StockMarketWire
19-07-16Initiation of European ovarian cancer studyRNS
15-07-16Notice of ResultsRNS
15-07-16Parsortix gaining traction at EACR ConferenceRNS
01-06-16Holding(s) in CompanyRNS
31-05-16Holding(s) in CompanyRNS
27-05-16Edison research update on AngleStockMarketWire
27-05-16Edison issues research update on AngleRNS
25-05-16ANGLE wins contract with Cancer Research UKStockMarketWire
25-05-16Cancer Research UK ContractRNS
22-04-16AIM share tips 2016: the first four monthsInteractive Investor
19-04-16Edison research update on AngleStockMarketWire
19-04-16Edison issues research update on AngleRNS
18-04-16ANGLE's Parsortix potential in metastatic breast cancerStockMarketWire
18-04-16Parsortix potential in metastatic breast cancerRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool
21-03-16Edison issues research update on AngleRNS
21-03-16Parsortix potential for prostate cancer detectionRNS
09-03-16ANGLE granted European patent for ParsortixStockMarketWire
09-03-16European patent grant for ParsortixRNS
28-01-16Interim ResultsRNS
27-01-16Notice of Interim ResultsRNS
25-01-16UKE evaluation of ANGLE's Parsortix published StockMarketWire
25-01-16UKE publishes evaluation of ParsortixRNS
31-12-15AIM share tips for 2016Interactive Investor

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory